ICE Chemotherapy for Lymphoma IFOSFAMIDE 5 g/m2 mixed with 5 g/m2 MESNA C.I. over 24 hours on DAY 2 CARBOPLATIN AUC=5 (capped at 800 mg) IVB on DAY 2 ETOPOSIDE 100 mg/m2 IVB on DAY1,2,3 GCSF 5 ug/kg DAYS 5-12 for the first 2 cycles GCSF 10 ug/kg beginning on DAY 5 of 3rd cycle and continuing through leukapheresis Cycles to be administered every 14 days for a total of 3 cycles REF: Blood 96:2399, 2000 High-dose chemotherapy and autologous stem cell transplant for patients with primary refractory aggressive non-hodgkin lymphoma: an intention to treat analysis. (N=85) All patients CR=14 PR=29 ORR=50.6% ___________________________________________ EPOCH Regimen (followed by SCT): Etoposide 200 mg/m2 IV 96 hr CI Doxorubicin 40 mg/m2 IV 96 hr CI Vincristine 1.6 mg/m2 IV 96 hr CI Cyclophosphamide 750 mg/m2 IV on DAY-5 Prednisone 60 mg/m2 QD X 5 days (DAY-1 to DAY-5) Dose reduce cyclophosphamide by 25% if ANC<500/ul Delay therapy if DAY-1 ANC<1000/ul REF: JCO 18:3135, 2000 5-year survival (EPOCH without SCT): 37% Overall response (all patients): 74% (24% CR) ___________________________________________ ESHAP Etoposide 40 mg/m2 IV days 1-4 Methylprednisolone 500 mg IV days 1-4 Cytarabine 2000 mg/m2 IV day 5 Cisplatin 25 mg/m2 CIV days 1-4 Ref: Velasquez W, et al: Proc ASCO 8:256 (abstract) (1986). Cabanillas F: Ann Oncol 2 (suppl 1):31-32, 1991. Cabanillas F, Rodiquez A, Swan F, et al: Proc Am Soc Clin Oncol 10:273, 1991. ___________________________________________
|